Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1074 | 1050 | 1107 | 1070 | 1125 | 1457 |
Fund Return | 7.43% | 5.03% | 10.69% | 2.27% | 2.39% | 3.84% |
Place in category | 1766 | 1480 | 1719 | 1625 | 1440 | 773 |
% in Category | 82 | 68 | 86 | 90 | 99 | 87 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Uni Global Equities Europe RA EUR | 174.86M | 7.71 | 3.11 | 4.83 | ||
Uni Global Equities Europe SA EUR | 174.86M | 7.61 | 2.68 | 4.28 | ||
Uni Global Equities Europe SD EUR | 174.86M | 9.12 | 3.04 | 4.08 | ||
Uni Glbl Eq Eurozone SA EUR | 50.47M | -8.50 | 3.09 | - | ||
Uni Glbl Eq EM SAC EUR | 33.51M | 4.49 | 0.51 | 2.15 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund Y Acc EUR | 136.15M | 8.71 | 5.97 | 6.00 | ||
European Growth Fund A DIST Eue | 6.33B | 8.40 | 5.09 | 5.14 | ||
European Growth Fund Y DIST EUR | 63.07M | 8.72 | 5.97 | 6.00 | ||
European Growth Fund A Acc EUR | 174.87M | 8.37 | 5.07 | 5.13 | ||
European Growth Fund E Acc EUR | 20.99M | 8.03 | 4.29 | 4.35 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SAP | DE0007164600 | 3.50 | 186.925 | +0.49% | |
Novartis | CH0012005267 | 3.49 | 95.60 | -0.34% | |
Roche Holding Participation | CH0012032048 | 3.24 | 251.20 | +0.64% | |
Nestle | CH0038863350 | 3.00 | 93.02 | +0.13% | |
Novo Nordisk ADR | US6701002056 | 2.97 | 143.67 | -2.21% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review